ProofPilot Acquires Lokavant to Enhance Clinical Trial Analytics

Sep 16, 2025
ProofPilot has acquired Lokavant to integrate predictive analytics into its clinical trial platform, enhancing trial execution and data insights.

ProofPilot has acquired Lokavant, a leader in clinical trial intelligence, to integrate predictive analytics into its platform, announced in a press release. This acquisition aims to combine ProofPilot's trial execution capabilities with Lokavant's advanced analytics, offering a comprehensive solution for optimizing clinical research.

Lokavant, spun out of Roivant in 2020, uses historical and real-time data to provide predictive insights and improve study feasibility. By integrating these capabilities, ProofPilot enhances its platform, allowing sponsors and CROs to anticipate challenges and drive faster, more reliable outcomes.

The combined platform offers AI-powered study forecasting, real-time performance dashboards, and enhanced study oversight capabilities. This integration is designed to improve operational predictability, reduce risk, and ensure trials generate reliable results, ultimately accelerating the delivery of new therapies to patients.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Guide
Specialist Ambient Medical Scribe Vendors

Specialist Ambient Medical Scribe Vendors

AI scribes that turn medical consultations into draft clinical notes

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.